What is MannKind Corp (MNKD) stock price today?

MannKind Corp (MNKD) currently trades at $2.75 per share. The stock has a market capitalization of $849.19M and a P/E ratio of 137.50x.

Is MNKD stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MannKind Corp has a Smart Value Score of 35/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the MNKD stock price target for 2026?

WallStSmart's 12-month price target for MannKind Corp is $0.14.

What is MannKind Corp's revenue and earnings?

MannKind Corp has trailing twelve-month (TTM) revenue of $348.97M with profit margins of 1.68%. Earnings per share (EPS) is $0.02.

MNKD

MannKind Corp

NASDAQ: MNKD · HEALTHCARE · BIOTECHNOLOGY

$2.75

-1.43% today

Updated 2026-04-29

Market cap

$849.19M

P/E ratio

137.50

P/S ratio

2.43x

EPS (TTM)

$0.02

Dividend yield

—

52W range

$2 – $7

Volume

6.3M

Market cap

$849.19M

P/E ratio

137.50

P/S ratio

2.43x

EPS (TTM)

$0.02

Dividend yield

—

52W range

$2 – $7

Volume

6.3M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

7.3

Growth

B+

5.0

Quality

C+

4.0

Profitability

3.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$6.94

+152.36%

12-Month target

$0.14

-94.91%

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 45.80% QoQ

Risks

- Thin margins at 1.68%

- Negative free cash flow $-9.95M

- P/E 137.50x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$99.77M	$198.96M	$285.50M	$348.97M	$348.97M
Net income	$-87.40M	$-11.94M	$27.59M	$5.86M	$-15.95M
EPS	—	—	—	—	$0.02
Free cash flow	$-88.29M	$-8.35M	$32.82M	$13.69M	$-9.95M
Profit margin	-87.60%	-6.00%	9.66%	1.68%	1.68%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-23	TROSS, STUART A	Buy	221,000	—
2026-03-23	TROSS, STUART A	Buy	217,000	—
2026-03-23	THOMSON, DAVID	Buy	221,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MNKD	$849.19M	35	7.3	4.0	3.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MannKind Corp trades at $2.75. representing a P/E of 137.50x trailing earnings. Our Smart Value Score of 35/100 indicates the stock is weak. TTM revenue stands at $348.97M. with profit margins at 1.68%.

Frequently asked questions

What is MannKind Corp's stock price?

MannKind Corp (MNKD) trades at $2.75.

Is MannKind Corp overvalued?

Smart Value Score 35/100 (Grade D, Sell).

What is the price target of MannKind Corp (MNKD)?

The analyst target price is $6.94, representing +152.4% upside from the current price of $2.75.

What is MannKind Corp's revenue?

TTM revenue is $348.97M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.43x

ROE—

Beta1.04

50D MA$2.98

200D MA$4.63

Shares out0.31B

Float0.30B

Short ratio—

Avg volume6.3M

Performance

1 week+2.95%

1 month+13.88%

3 months-51.81%

YTD-50.79%

1 year—

3 years—

5 years—

Compare

MNKD vs LLY →MNKD vs JNJ →MNKD vs ABBV →Stock screener →